Can Daily Aspirin Prevent Both Heart Disease and Cancer?

Laura Gottschalk, Ph.D., Sasha Milbeck & Meg Seymour, PhD

Many adults take a low-dose aspirin (or “baby” aspirin) to prevent heart disease and possibly cancer. The most recent data indicates that in 2017, 23% of U.S. adults over 40 who did not have heart disease took low-dose aspirin to help prevent developing it.1 About 23% of people taking “baby” aspirin daily reported that they did so without a doctor recommending it. Should you take daily aspirin to prevent heart disease? The recommendations depend on your age, as well as other risk factors.

In April 2022, the United States Preventive Services Task Force (USPSTF) issued updated recommendations that people over 60 should not start taking low-dose aspirin, because the benefits do not outweigh the risks.2 For those ages 40-59 with a 10% or more chance of developing heart disease over the next 10 years, the USPSTF says the data are unclear. So, the decision to start taking low-dose aspirin should be made with one’s physician, weighing the risks (which vary among individuals) against the small benefits.

These recommendations are notably different from the USPSTF’s 2016 recommendations, which did not recommend against starting to take low-dose aspirin for those ages 60-69. The 2016 recommendations also recommended adults ages 50-59 with a 10% or more chance of developing heart disease over the next 10 years and who were willing to take daily aspirin for those 10 years begin to do so.3

What Are the Benefits and Risks?

Why have the recommendations changed over time, and what do we now know about the cardiovascular benefits of taking low-dose aspirin that we didn’t know a few years ago? A 2019 study combined the results of 13 clinical trials, all comparing daily aspirin to placebo or to no treatment.4 The combination study, called a meta-analysis, analyzed over 164,000 patients, who were followed for an average of five years. The researchers found that patients who used daily aspirin had fewer heart attacks and fewer ischemic strokes. However, the authors also found that people who took daily aspirin were more likely to have intracranial bleeding (inside the skull) and major gastrointestinal bleeding.

The USPSTF reviewed the research on low-dose aspirin in order to develop their recommendation, and drew similar conclusions.5 The analysis of over 161,000 patients found that people taking daily aspirin reduced their chances of a having at least one major cardiovascular event such as a heart attack or stroke by 2.5%. And yet, the analysis also found that people taking “baby” aspirin were not less likely to die from heart attacks or strokes. In addition, people taking daily aspirin were 1% more likely to experience major bleeding, such as gastrointestinal bleeding that resulted in a transfusion, hospital admission, intracranial bleeding, or death.

It is important to know who is most likely to experience harmful bleeding. Research has shown that the increased chances of bleeding begins relatively soon after starting to take “baby” aspirin on a daily basis, and it increases with age. Bleeding is more common among men, smokers, people with high blood pressure, people with liver disease, people with diabetes, and people with a history of gastrointestinal problems, such as peptic ulcer disease.5 Taking certain medications can also increase the risk of bleeding, including nonsteroidal anti-inflammatory drugs (such as ibuprofen or naproxen), steroids (such as prednisone), and anticoagulants (such as warfarin). We agree with the USPSTF recommendation that these factors make dangerous bleeding more likely for anyone taking daily aspirin.

In a 2023 meta-analysis of 16 studies, researchers compared the risks and benefits of low-dose aspirin in adults who did not have cardiovascular disease who use statins to those who did not use statins.6 Statins are a group of drugs that lower LDL or “bad” cholesterol by helping the body slow down cholesterol production and rev up cholesterol removal. Researchers found that at every level of cardiovascular disease risk, the chances of developing major bleeding complications from daily aspirin were greater than the chances of the aspirin preventing heart attacks or other cardiovascular problems. That was true for patients taking low-dose aspirin alone or with a statin. For that reason, statins alone are now considered safer than low-dose aspirin for preventing heart attacks even for those with little or no risk.

According to the USPSTF, the benefits of daily aspirin use are different for someone in their 60s or 70s who has already been taking low-dose aspirin compared to someone in their 60s or 70s who is considering whether to start to take daily aspirin. For people already taking daily aspirin, the benefits become smaller with age, because the chance of serious bleeding increases with age.  Modeling data suggest it may be a good choice to consider stopping taking regular aspirin after around 75. However, stopping daily aspirin can lead to a “rebound” effect where the chances of cardiovascular events increases slightly within the first few weeks that is maintained for at least one year.7 The increased risk means that about one out of every 74 patients (1.4%) who discontinue use will experience a cardiovascular event, such as heart attack or stroke. The risk is higher than 1.4% for people who previously had a CVD event and lower for those who took daily aspirin to prevent a first CVD event.8 If you are currently taking daily low-dose aspirin and want to consider stopping, speak with your doctor about how to safely taper your use.

Does Daily Aspirin Prevent Cancer?

The USPSTF also reviewed scientific studies of whether daily low-dose aspirin can help prevent colorectal cancer. They found that four studies following patients for up to 10 years found no evidence that taking daily aspirin reduced the chances of developing colorectal cancer.5

The 2019 paper mentioned above also found that daily aspirin did not reduce the chances of dying of cancer, compared with no aspirin.4 In fact, one clinical trial in that meta-analysis (called ASPREE: Aspirin in Reducing Events in the Elderly) found that individuals who took aspirin were slightly more likely to die from cancers. Researchers analyzed the overall chance of dying from 14 common cancers, including colorectal cancer, and found that 3.1% of the participants taking daily aspirin had died a cancer-related death at five years follow-up, compared with 2.3% of those taking a placebo.9 This is a small difference but is it conclusive? Most participants in the ASPREE trial had never used low-dose aspirin regularly before joining the study, and that made it impossible to determine if taking “baby” aspirin regularly for many years is likely to increase or decrease the chances of dying of cancer.

However, a more recent, longer-term study, published in 2021 found that people who started using low-dose aspirin regularly at a younger age and who continued after age 70 were less likely to develop colorectal cancer than people who didn’t use low-dose aspirin.10 That study combined 2 large studies that included almost 95,000 patients.

The USPSTF 2022 analysis notes that the evidence about daily aspirin and colorectal cancer is highly variable, with randomized clinical trials showing no benefit and some long-term observational studies showing some possible benefit.11 Given these inconsistent results, the USPSTF does not recommend that older patients begin taking low-dose aspirin for the sole purpose of preventing colorectal cancer.

The Bottom Line: Should I Take a Daily Aspirin?

Overall, the choice to begin taking low-dose aspirin (or to continue if you are already taking it) should be a decision that you make with your healthcare provider, after weighing the potential risks and benefits. The research described above is a good reminder that aspirin is a drug that has risks even at low doses. For many people, aspirin’s risk of serious bleeding may outweigh the benefits of decreased cardiovascular events. However, if you have been taking low-dose aspirin, stopping to take it also has risks, especially if you previously had a cardiovascular event such as a heart attack or stroke. When discussing with your healthcare provider the possibility of taking daily aspirin, let them know:

  •       Your medical history and all the medicines you are currently using, whether they are prescription or over-the-counter,
  •       Any allergies or sensitivities you may have to aspirin, and
  •       Any vitamins or dietary supplements you are currently taking

To read our comments made to the USPSTF about their 2021 updates to their recommendation statement, click here.

Other Ways to Prevent Heart Disease and Cancer

In 2022, heart disease and cancer were the leading causes of death in adults in the United States.

To reduce your risk of heart disease, don’t smoke, exercise regularly, keep your cholesterol and blood pressure under control, and do what you need to do to prevent diabetes.  Being a man and being older also put you at risk, but those are factors you can’t control.

To reduce your risk of colorectal cancer, don’t smoke, don’t drink alcohol in excess, have a healthy diet, stay physically active, and maintain a healthy weight.  Being older, and having a family history of colon cancer, Crohn’s disease, or ulcerative colitis are the risk factors you can’t control.

All articles are reviewed and approved by Dr. Diana Zuckerman and other senior staff.

The National Center for Health Research is a nonprofit, nonpartisan research, education and advocacy organization that analyzes and explains the latest medical research and speaks out on policies and programs. We do not accept funding from pharmaceutical companies or medical device manufacturers. Find out how you can support us here.


  1. O’Brien CW, Juraschek SP, Wee CC. Prevalence of aspirin use for primary prevention of cardiovascular disease in the United States: results from the 2017 National Health Interview Survey. Annals of Internal Medicine. 2019 Oct 15;171(8):596-8.
  2. Final Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication. April 26, 2022
  3. Final Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication. April 11, 2016.
  4. Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019;321(3):277-87.
  5. Guirguis-Blake JM, Evans CV, Perdue LA, Bean SI, Senger CA. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 211. Rockville, MD: Agency for Healthcare Research and Quality; 2021. AHRQ publication no. 21-05283-EF-1.
  6. Khan SU, Lone AN, Kleiman NS, Arshad A, Jain V, Al Rifai M, et al. Aspirin With or Without Statin in Individuals Without Atherosclerotic Cardiovascular Disease Across Risk Categories. JACC: Advances. 2023 Feb;100197.
  7.  Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Archives of Neurology. 2005; 62(8):1217-20.
  8. Sundström J, Hedberg J, Thuresson M, Aarskog P, Johannesen KM, Oldgren J. Low-dose aspirin discontinuation and risk of cardiovascular events: a Swedish nationwide, population-based cohort study. Circulation. 2017; 136(13):1183-92.
  9. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, Kirpach B, Shah RC, Ives DG, Storey E, Ryan J. Effect of aspirin on all-cause mortality in the healthy elderly. New England Journal of Medicine. 2018; 379(16):1519-28.
  10.  Guo C, Ma W, Drew DA, et al. Aspirin Use and Risk of Colorectal Cancer Among Older Adults. JAMA Oncology. Published online January 21, 2021. doi:10.1001/jamaoncol.2020.7338
  11. Mora S, Shufelt CL, Manson JE. Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma. JAMA Intern Med. Published online April 26, 2022. doi:10.1001/jamainternmed.2022.1365